Marvell Technology, Inc. (MRVL) NASDAQ
172.15
+3.4(+2.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
172.15
+3.4(+2.01%)
Currency In USD
| Previous Close | 168.75 |
| Open | 172.62 |
| Day High | 175.79 |
| Day Low | 165 |
| 52-Week High | 175.79 |
| 52-Week Low | 53.78 |
| Volume | 23.2M |
| Average Volume | 22.82M |
| Market Cap | 150.54B |
| PE | 56.07 |
| EPS | 3.07 |
| Moving Average 50 Days | 113.34 |
| Moving Average 200 Days | 89.36 |
| Change | 3.4 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX